Dissecting the tumour immune microenvironment in merkel cell carcinoma based on a machine learning framework
Source abstract
Abstract
Merkel cell carcinoma (MCC) is a primary cutaneous neoplasm of neuroendocrine carcinoma of the skin, which is characterized by molecular heterogeneity with diverse tumour microenvironment (TME). However, we are still lack knowledge of the cellular states and ecosystems in MCC. Here, we systematically identified and characterized the landscape of cellular states and ecotypes in MCC based on a machine learning framework. We obtained 30 distinct cellular states from 9 immune cell types and investigated the B cell, CD8 T cell, fibroblast, and monocytes/macrophage cellular states in detail. The functional profiling of cellular states were investigated and found the genes highly expressed in cellular states were significantly enriched in immune- and cancer hallmark-related pathways. In addition, four ecotypes were further identified which were with different patient compositions. Transcriptional regulation analysis revealed the critical transcription factors (i.e. E2F1, E2F3 and E2F7), which play important roles in regulating the TME of MCC. In summary, the findings of this study may provide rich knowledge to understand the intrinsic subtypes of MCCs and the pathways involved in distinct subtype oncogenesis, and will further advance the knowledge in developing a specific therapeutic strategy for these MCC subtypes.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Polyomavirus and related diseases · Plant Virus Research Studies · Microwave Engineering and Waveguides
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Wound Repair, The First Affiliated Hospital of Hainan Medical University, Haikou, China
College of Biomedical Information and Engineering, Hainan Medical University, Haikou, China
Department of Radiotherapy, The First Affiliated Hospital of Hainan Medical University, Haikou, China
The First Affiliated Hospital of Hainan Medical University, Haikou, China
Funding
National Science Foundation of China · Hainan Province Science and Technology Special Fund · Hainan Provincial Health and Family Planning Commission Project
References (65)
Show source-provided references
1. 10.1038/nrdp.2017.7710.1038/nrdp.2017.77 ↗
2. 10.1146/annurev-pathmechdis-012419-03281710.1146/annurev-pathmechdis-012419-032817 ↗
3. 10.1126/science.115258610.1126/science.1152586 ↗
4. 10.1093/jnci/djp13910.1093/jnci/djp139 ↗
5. 10.3389/fimmu.2022.95499210.3389/fimmu.2022.954992 ↗
6. 10.3389/fonc.2022.97027910.3389/fonc.2022.970279 ↗
7. 10.1038/nm.339410.1038/nm.3394 ↗
8. 10.1158/2326-6066.CIR-13-003410.1158/2326-6066.CIR-13-0034 ↗
9. 10.1016/j.humpath.2016.02.00210.1016/j.humpath.2016.02.002 ↗
10. 10.1158/1078-0432.CCR-16-039210.1158/1078-0432.CCR-16-0392 ↗
11. 10.4049/jimmunol.178.9.559510.4049/jimmunol.178.9.5595 ↗
12. 10.1182/blood-2006-06-02935510.1182/blood-2006-06-029355 ↗
13. 10.1038/sj.leu.240455910.1038/sj.leu.2404559 ↗
14. 10.1080/2162402X.2018.142651710.1080/2162402X.2018.1426517 ↗
15. 10.1038/jid.2014.51810.1038/jid.2014.518 ↗
16. 10.1038/jid.2012.44510.1038/jid.2012.445 ↗
17. 10.1002/ijc.2572010.1002/ijc.25720 ↗
18. 10.1002/ijc.2467610.1002/ijc.24676 ↗
19. 10.1038/s41467-020-14802-210.1038/s41467-020-14802-2 ↗
20. 10.1093/nar/gkab104110.1093/nar/gkab1041 ↗
21. 10.1016/j.immuni.2018.03.02310.1016/j.immuni.2018.03.023 ↗
22. 10.1016/j.cell.2021.09.01410.1016/j.cell.2021.09.014 ↗
23. 10.1016/j.molcel.2019.05.00310.1016/j.molcel.2019.05.003 ↗
24. 10.1016/j.cell.2021.09.02810.1016/j.cell.2021.09.028 ↗
25. 10.1016/j.ccell.2021.09.00610.1016/j.ccell.2021.09.006 ↗
26. 10.1038/s41587-019-0114-210.1038/s41587-019-0114-2 ↗
27. 10.1101/gr.123930310.1101/gr.1239303 ↗
28. 10.1089/omi.2011.011810.1089/omi.2011.0118 ↗
29. 10.1016/j.gpb.2022.04.00810.1016/j.gpb.2022.04.008 ↗
30. 10.1016/j.cels.2015.12.00410.1016/j.cels.2015.12.004 ↗
31. 10.1038/sdata.2018.1510.1038/sdata.2018.15 ↗
32. 10.1073/pnas.050658010210.1073/pnas.0506580102 ↗
33. 10.1080/15592294.2020.177309610.1080/15592294.2020.1773096 ↗
34. 10.3389/fonc.2019.0045110.3389/fonc.2019.00451 ↗
35. 10.1155/2012/68041010.1155/2012/680410 ↗
36. 10.1242/dev.12314110.1242/dev.123141 ↗
37. 10.1007/s40257-019-00427-910.1007/s40257-019-00427-9 ↗
38. 10.1038/modpathol.380093610.1038/modpathol.3800936 ↗
39. 10.1158/0008-5472.CAN-13-061610.1158/0008-5472.CAN-13-0616 ↗
40. 10.1126/science.aat503010.1126/science.aat5030 ↗
41. 10.4161/auto.2348410.4161/auto.23484 ↗
42. 10.1038/nrclinonc.2013.4610.1038/nrclinonc.2013.46 ↗
43. 10.4049/jimmunol.160008910.4049/jimmunol.1600089 ↗
44. 10.1182/blood-2010-10-31412010.1182/blood-2010-10-314120 ↗
45. 10.1038/nrc.2016.7310.1038/nrc.2016.73 ↗
46. 10.1038/s41388-020-01576-610.1038/s41388-020-01576-6 ↗
47. 10.1016/j.immuni.2014.06.01010.1016/j.immuni.2014.06.010 ↗
48. 10.1038/s41577-019-0127-610.1038/s41577-019-0127-6 ↗
49. Qiu H · Asian Pac J Cancer Prev · 2011 · 12 · 791
50. 10.3389/fimmu.2021.75347710.3389/fimmu.2021.753477 ↗
51. 10.1002/jcsm.1275810.1002/jcsm.12758 ↗
52. 10.1002/hon.305010.1002/hon.3050 ↗
53. 10.7717/peerj.865410.7717/peerj.8654 ↗
54. 10.1038/nrc.2016.14510.1038/nrc.2016.145 ↗
55. 10.1016/j.jid.2021.01.01210.1016/j.jid.2021.01.012 ↗
56. 10.1016/j.cytogfr.2016.02.00110.1016/j.cytogfr.2016.02.001 ↗
57. 10.1172/JCI8758310.1172/JCI87583 ↗
58. 10.1038/s41571-018-0103-210.1038/s41571-018-0103-2 ↗
59. 10.3389/fimmu.2021.64369210.3389/fimmu.2021.643692 ↗
60. 10.1186/s13046-021-02128-w10.1186/s13046-021-02128-w ↗
61. 10.1016/S0140-6736(02)07668-710.1016/S0140-6736(02)07668-7 ↗
62. 10.1186/s12943-021-01428-110.1186/s12943-021-01428-1 ↗
63. 10.1038/s41392-021-00484-910.1038/s41392-021-00484-9 ↗
64. 10.7150/thno.5177710.7150/thno.51777 ↗
65. 10.1152/physrev.00048.201910.1152/physrev.00048.2019 ↗